Cefadroxil Micronised Powder

Cefadroxil Micronised Powder Brand names, Cefadroxil Micronised Powder Analogs

Cefadroxil Micronised Powder Brand Names Mixture

None

Cefadroxil Micronised Powder Chemical_Formula

C₁₆H₁₇N₃O₅S

Cefadroxil Micronised Powder RX_link

http://www.rxlist.com/cgi/generic/cefadrox.htm

Cefadroxil Micronised Powder fda sheet

Cefadroxil Micronised Powder msds (material safety sheet)

Cefadroxil Micronised Powder Synthesis Reference

L. B. Crast, Jr., U.S. Pat. 3,489,752 (1969)

Cefadroxil Micronised Powder Molecular Weight

363.389 g/mol

Cefadroxil Micronised Powder Melting Point

197^oC

Cefadroxil Micronised Powder H₂O Solubility

1110 mg/L

Cefadroxil Micronised Powder State

Solid

Cefadroxil Micronised Powder LogP

-0.355

Cefadroxil Micronised Powder Dosage Forms

Capsule; Tablet; Oral liquid

Cefadroxil Micronised Powder Indication

For the treatment of the following infections (skin, UTI, ENT) caused by; S. pneumoniae, H. influenzae, staphylococci, S. pyogenes (group A beta-hemolytic streptococci), E. coli, P. mirabilis, Klebsiella sp, coagulase-negative staphylococci and Streptococcus pyogenes

Cefadroxil Micronised Powder Pharmacology

Cefadroxil, a first-generation cephalosporin antibiotic, is used to treat urinary tract infections, skin and skin structure infections, pharyngitis, and tonsillitis.

Cefadroxil Micronised Powder Absorption

Cefadroxil is well absorbed on oral administration; food does not interfere with its absorption.

Cefadroxil Micronised Powder side effects and Toxicity

Nausea, vomiting, diarrhoea, allergic rashes may occur

Cefadroxil Micronised Powder Patient Information

Patients should be counseled that intibacterial drugs including DURICEF should only be used to treat bacterial infections. They do not treat viral infections (eg. the common cold). When DURICEF is prescribed to treat a bacterial infection, patients should be told that although it is common to feel better early in the course of therapy, the medication should be taken exactly as directed. Skipping doses or not completing the full course of therapy may (1) decrease the effectiveness of the immediate treatment and (2) increase the likelyhood that bacteria will develop resistance and will not be treatable by DURICEF or other antibacterial drugs in the future.

Cefadroxil Micronised Powder Organisms Affected

Enteric bacteria and other eubacteria